1
|
Ordás I, Eckmann L, Talamini M, Baumgart
DC and Sandborn WJ: Ulcerative colitis. Lancet. 380:1606–1619.
2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Gillen CD, Walmsley RS, Prior P, Andrews
HA and Allan RN: Ulcerative colitis and Crohn's disease: A
comparison of the colorectal cancer risk in extensive colitis. Gut.
35:1590–1592. 1994. View Article : Google Scholar : PubMed/NCBI
|
3
|
Wang Z: MicroRNA: A matter of life or
death. World J Biol Chem. 1:41–54. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kinose Y, Sawada K, Nakamura K and Kimura
T: The role of MicroRNAs in ovarian cancer. Biomed Res Int.
2014:2493932014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Shen N, Huang X and Li J: Upregulation of
miR-129-5p affects laryngeal cancer cell proliferation,
invasiveness, and migration by affecting STAT3 expression. Tumour
Biol. 37:1789–1796. 2016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Yang Y, Ma Y, Shi C, Chen H, Zhang H, Chen
N, Zhang P, Wang F, Yang J, Yang J, et al: Overexpression of miR-21
in patients with ulcerative colitis impairs intestinal epithelial
barrier function through targeting the Rho GTPase RhoB. Biochem
Biophys Res Commun. 434:746–752. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Polytarchou C, Hommes DW, Palumbo T,
Hatziapostolou M, Koutsioumpa M, Koukos G, van der Meulen-de Jong
AE, Oikonomopoulos A, van Deen WK, Vorvis C, et al: MicroRNA214 is
associated with progression of ulcerative colitis, and inhibition
reduces development of colitis and colitis-associated cancer in
mice. Gastroenterology. 149:981–992.e11. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ranjha R, Meena NK, Singh A, Ahuja V and
Paul J: Association of miR-196a-2 and miR-499 variants with
ulcerative colitis and their correlation with expression of
respective miRNAs. PLoS One. 12:e01734472017. View Article : Google Scholar : PubMed/NCBI
|
9
|
Lewis A, Felice C, Kumagai T, Lai C, Singh
K, Jeffery RR, Feakins R, Giannoulatou E, Armuzzi A, Jawad N, et
al: The miR-200 family is increased in dysplastic lesions in
ulcerative colitis patients. PLoS One. 12:e01736642017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Shi CC: Study on the mechanism of miRNA-21
in regulating intestinal barrier function and inflammation related
colon cancer. Shanghai Jiaotong University; 2014
|
11
|
Thorlacius-Ussing G, Nielsen BS, Andersen
V, Holmstrøm K and Pedersen AE: Expression and localization of
miR-21 and miR-126 in mucosal tissue from patients with
inflammatory bowel disease. Inflamm Bowel Dis. 23:739–752. 2017.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Gryshkova V, Fleming A, McGhan P, De Ron
P, Fleurance R, Valentin JP and Nogueira da Costa A: miR-21-5p as a
potential biomarker of inflammatory infiltration in the heart upon
acute drug-induced cardiac injury in rats. Toxicol Lett. 286:31–38.
2018. View Article : Google Scholar : PubMed/NCBI
|
13
|
Buoli Comani G, Panceri R, Dinelli M,
Biondi A, Mancuso C, Meneveri R and Barisani D: miRNA-regulated
gene expression differs in celiac disease patients according to the
age of presentation. Genes Nutr. 10:4822015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Zhang T: Study on the relationship between
intestinal barrier and STAT3 signaling pathway in ulcerative
colitis. Tianjin Medical University; 2013
|
15
|
Li T, Zhu XD, Yang Y and Zhai YH: Effect
of tongxie yaofang on the expression of IL-6 and IL6R in the
hypothalamus of rats with ulcerative colitis. Chin J Exp Trad Med
Formulae. 23:103–108. 2017.
|
16
|
Wang Q, Bie YL, Wang D and Fan WT: Effect
of dandelion polysaccharide on IL-6 /STAT3 signaling pathway in
ulcerative colitis rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi.
33:422–425. 2017.(In Chinese). PubMed/NCBI
|
17
|
Murthy S, Cooper HS, Yoshitake H, Meyer C,
Meyer CJ and Murthy NS: Combination therapy of pentoxifylline and
TNFalpha monoclonal antibody in dextran sulphate-induced mouse
colitis. Aliment Pharmacol Ther. 13:251–260. 1999. View Article : Google Scholar : PubMed/NCBI
|
18
|
Cooper HS, Murthy SN, Shah RS and
Sedergran DJ: Clinicopathologic study of dextran sulfate sodium
experimental murine colitis. Lab Invest. 69:238–249.
1993.PubMed/NCBI
|
19
|
Paiotti AP, Ribeiro DA, Silva RM, Marchi
P, Oshima CT, Neto RA, Miszputen SJ and Franco M: Effect of COX-2
inhibitor lumiracoxib, the anti-TNF-α etanercept and your
association on TNBS-induced colitis in Wistar rats. J Mol Histol.
43:307–317. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Dieleman LA, Palmen MJ, Akol H, Bloemena
E, Peña AS, Meuwissen SG and Van Rees EP: Chronic experimental
colitis induced by dextran sulphate sodium (DSS) is characterized
by Th1 and Th2 cytokines. Clin Exp Immunol. 114:385–391. 1998.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Agarwal V, Bell GW, Nam J and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Li Z, Wang Y and Zhu Y: Association of
miRNA-146a rs2910164 and miRNA-196 rs11614913 polymorphisms in
patients with ulcerative colitis: A meta-analysis and review.
Medicine (Baltimore). 97:e122942018. View Article : Google Scholar : PubMed/NCBI
|
24
|
Deng S, Wang H, Fan H, Zhang L, Hu J, Tang
Q, Shou Z, Liu X, Zuo D, Yang J, et al: Over-expressed miRNA-200b
ameliorates ulcerative colitis-related colorectal cancer in mice
through orchestrating epithelial-mesenchymal transition and
inflammatory responses by channel of AKT2. Int Immunopharmacol.
61:346–354. 2018. View Article : Google Scholar : PubMed/NCBI
|
25
|
Huang Y, Ma Z, Cui YH, Dong HS, Zhao JM,
Dou CZ, Liu HR, Li J and Wu HG: Effects of herb-partitioned
moxibustion on the miRNA expression profiles in colon from rats
with DSS-induced ulcerative colitis. Evid Based Complement Alternat
Med. 2017:7673012017. View Article : Google Scholar
|
26
|
Liu Z, Yu M, Fei B, Fang X, Ma T and Wang
D: miR-21-5p targets PDHA1 to regulate glycolysis and cancer
progression in gastric cancer. Oncol Rep. 40:2955–2963.
2018.PubMed/NCBI
|
27
|
Fromm B, Tosar JP, Lu Y, Halushka MK and
Witwer KW: Human and cow have identical miR-21-5p and miR-30a-5p
sequences, which are likely unsuited to study dietary uptake from
cow milk. J Nutr. 148:1506–1507. 2018. View Article : Google Scholar : PubMed/NCBI
|
28
|
Li Q, Li B, Li Q, Wei S, He Z, Huang X,
Wang L, Xia Y, Xu Z, Li Z, et al: Exosomal miR-21-5p derived from
gastric cancer promotes peritoneal metastasis via
mesothelial-to-mesenchymal transition. Cell Death Dis. 9:8542018.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Li XH, Chen D, Li M, Gao X, Shi G and Zhao
H: The CADM2/Akt pathway is involved in the inhibitory effect of
miR-21-5p downregulation on proliferation and apoptosis in
esophageal squamous cell carcinoma cells. Chem Biol Interact.
288:76–82. 2018. View Article : Google Scholar : PubMed/NCBI
|
30
|
Lakhter AJ, Pratt RE, Moore RE, Doucette
KK, Maier BF, DiMeglio LA and Sims EK: Beta cell extracellular
vesicle miR-21-5p cargo is increased in response to inflammatory
cytokines and serves as a biomarker of type 1 diabetes.
Diabetologia. 61:1124–1134. 2018. View Article : Google Scholar : PubMed/NCBI
|
31
|
Ge XT, Huang S, Gao H, Han Z, Chen F,
Zhang S, Wang Z, Kang C, Jiang R, Yue S, et al: miR-21-5p
alleviates leakage of injured brain microvascular endothelial
barrier in vitro through suppressing inflammation and apoptosis.
Brain Res. 1650:31–40. 2016. View Article : Google Scholar : PubMed/NCBI
|
32
|
Hua Y, Drew P and Richard J: STATs in
cancer inflammation and immunity: A leading role for STAT3. Nat Rev
Cancer. 9:798–809. 2009. View
Article : Google Scholar : PubMed/NCBI
|
33
|
Dang V, Barbi J, Yang HY, Jinasena D, Yu
H, Zheng Y, Bordman Z, Fu J, Kim Y, Yen HR, et al: Control of
T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell.
146:772–784. 2011. View Article : Google Scholar : PubMed/NCBI
|
34
|
Liu JZ, Suzanne VS, Hailiang H, Ng SC,
Alberts R, Takahashi A, Ripke S, Lee JC, Jostins L, Shah T, et al:
Association analyses identify 38 susceptibility loci for
inflammatory bowel disease and highlight shared genetic risk across
populations. Nat Genet. 47:979–986. 2015. View Article : Google Scholar : PubMed/NCBI
|